Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-21 · accession 0001517026-22-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-22 | 2022-09-21 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $20.20 | -702 | 241.5K | -0.3% | -$14.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-21 | F | D | 702 | $20.20 | 241,474 | D | — | — |